Leonard Post

Leonard E.
Post was the founder of LEAD Therapeutics, Inc., founded in 2006, where the titles held included Director & Chief Scientific Officer from 2006 to 2012.
Current jobs include Director at BioVex, Inc. since 2007; Director at Altiris Therapeutics, Inc.; Director at Orphagen Pharmaceuticals; Director at Oxyrane UK Ltd.; Director at Infectious Disease Research Institute; Director at Fedora Pharmaceuticals, Inc. (Canada); Director at Grace Science LLC; Lead Independent Director at CG Oncology, Inc. since 2018; Independent Non-Executive Director at uniQure NV since 2020; Non-Executive Director at ImmVirX Pty Ltd.; and Director at AceLink Therapeutics, Inc. Former jobs include Director-Infectious Disease Research at The Upjohn Co.; Director at Praecis Pharmaceuticals, Inc.; Director at BioVex Group, Inc.; Non-Executive Director at Viralytics Pty Ltd. from 2011 to 2012; Director & Consultant at BioVex Ltd.; Director at Fulgent Genetics, Inc. in 2022; Director & Chief Scientific Officer at Vivace Therapeutics, Inc. from 2016 to 2024; Vice President-Research & Development at Warner-Lambert Co. from 1991 to 2000; Senior Vice President-Research & Development at Onyx Pharmaceuticals, Inc. from 2000 to 2006; Vice President-Research at Parke-Davis & Co. Ltd.; Professor at the University of Michigan from 1993 to 2000; Vice President-Discovery Research at Parke, Davis & Co. LLC; Chief Scientific Officer at Virtuoso Therapeutics, Inc. from 2018 to 2024; Vice President-Discovery Research at Parke-Davis Pharmaceuticals Ltd.; and Chief Scientific Officer at BioMarin Pharmaceutical, Inc. from 2010 to 2016.
Education includes a doctorate from the University of Wisconsin and an undergraduate degree from the University of Michigan.